JUUL LABS APPOINTS PRIYA SINGH TO BOARD OF DIRECTORS

Company News

April 30, 2025

Juul Labs is pleased to announce the appointment of Priya Singh, a distinguished leader in strategy, innovation and healthcare, to its Board of Directors. 

Since 2019, Ms. Singh has served as the Executive Vice President, Chief Strategy Officer, and Senior Associate Dean at Stanford Medicine, leading enterprise-wide global strategy and communications for the $14.1 billion academic health system. 

“Priya’s expertise at the intersection of global business operations, strategic growth, and patient-centered health innovation will be of enormous value to Juul leadership,” said K.C. Crosthwaite, Chairman and CEO of Juul Labs. “She’s a true leader and understands the potential of strategically scaling our work to advance our mission of helping adult smokers transition away from combustible cigarettes while combating underage use. Priya joins our board as Zach Frankel concludes his eight years of service. I am grateful to Zach for all of his contributions, strategic vision, and commitment to the company’s mission.”

“As a Juul Labs board member, I look forward to advising the business and leaders on advancing the mission in the U.S. and globally” said Ms. Singh.

Ms. Singh’s experience extends beyond health care, including leadership roles at the Stanford Graduate School of Business, Oracle, Respond.com, and Levi Strauss & Co. Her expertise has been recognized by Becker’s Hospital Review, Fortune’s Most Powerful Women, McKinsey’s Most Influential Women, and the Silicon Valley Business Journal’s Women of Influence.